Pfizer, Merck strike $2.85B deal as hope of AstraZeneca merger wanes
November 17, 2014 at 14:54 PM EST
Pfizer Inc. entered into an agreement Monday with Merck KGaA to jointly develop and commercialize an immunotherapy product that Merck KGaA has under development as a potential treatment for a variety of cancers...